Asherman Syndrome Clinical Trial
Official title:
Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy).
In the last years, platelet-rich plasma (PRP) has emerged as a promising alternative to treat endometrial pathologies affecting the endometrial lining. Different studies have tried this therapeutic approach in human patient, but results are not conclusive at all. Also, in the last years, different studies have suggested the umbilical cord blood has a stronger reservoir of growth factors and other pro-regenerative molecules than the adult peripheral blood. That is the reason why the present study aims to evaluate if using platelet-rich plasma obtained from umbilical cord blood is able to increase endometrial thickness and prepare the endometrium for an embryo transference. However, due to the novelty of this approach, the investigators have considered to include a 'proof of concept' group (women with premature ovarian insufficiency) to obtain a deeper understanding of the clinical value of this blood derivative.
Phase II clinical trial, designed as a pilot study, single-center and open-label, which aims to study the efficacy of platelet-rich plasma from umbilical cord after injection into a pathological endometrium (thin endometrium, Asherman's Syndrome, endometrial atrophy). This treatment will be applied to patients with the aforementioned endometrial pathologies (group B), as well as to patients with premature ovarian failure (group A), which will serve to study its clinical value in greater detail. Plasma samples as well as endometrial biopsies will be analyzed to try to understand what molecular events are triggered in the endometrial tissue after the application of the treatment under study. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04671914 -
Prevalence of Intrauterine Adhesions After D&C With or Without Antiadhesion Gel After Abortion in Second Trimester.
|
Phase 4 | |
| Completed |
NCT01377779 -
Efficiency of Intercoat (Oxiplex/AP Gel)in Decreasing Intrauterine Adhesions
|
N/A | |
| Recruiting |
NCT05521932 -
Establishment and Application of Endometrial 3D-organoid in Endometrial Injury Repair
|
||
| Completed |
NCT04424160 -
Effects of Platelet Rich Plasma on Endometrium
|
N/A | |
| Active, not recruiting |
NCT04963179 -
PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.
|
N/A | |
| Completed |
NCT05414760 -
Evaluate Formation of IUAs After Third-generation Endometrial Ablation, With and Without Intrauterine Adhesion Barrier
|
N/A | |
| Recruiting |
NCT05343572 -
Bone Marrow Derived Stem Cells Mobilization for Treatment of Abnormal Endometrium
|
Early Phase 1 | |
| Completed |
NCT02867202 -
Adjuvant Therapy for Intrauterine Adhesions Between Two Groups
|
N/A | |
| Recruiting |
NCT03665649 -
Pre-clinical Endometrial Tissular Renovation Study
|
N/A | |
| Recruiting |
NCT03249415 -
Use of PRP in Endometrial Reconstruction
|
||
| Completed |
NCT05901948 -
Pre-Surgical Grading System of Asherman Syndrome
|
||
| Completed |
NCT02746679 -
Impact of Mindfulness Based Stress Reduction on Anxiety, Depression and QOL in Women With Intrauterine Adhesion.
|
N/A | |
| Completed |
NCT02680366 -
Treatment of Severe Asherman Syndrome by Collagen Scaffold Loaded With Autologous Bone Marrow Mononuclear Cells
|
N/A | |
| Recruiting |
NCT01637974 -
Efficiency of INTERCOAT (Oxiplex/AP Gel) in Preventing Intrauterine Adhesion Formation in Hysteroscopic Surgery
|
N/A | |
| Completed |
NCT03166189 -
Autologous Bone Marrow-derived Mesenchymal Stem Cells for Atrophic Endometrium in Patients With Repeated IVF Failures
|
Phase 2 | |
| Enrolling by invitation |
NCT03620929 -
Estrogen in the Prevention of Adhesion Reformation
|
Phase 4 | |
| Completed |
NCT02726971 -
Comparison of Different Doses of Oestrogen Therapy for Preventing Intrauterine Adhesion
|
Phase 1/Phase 2 |